| Call Number (LC) | Title | Results |
|---|---|---|
| EP 5.8:EM 3/4 | Emergency Planning and Community Right-to-Know Act section 313 addendum to the guidance documents for the newly added industries | 1 |
| EP 5.8:EM 3/6 | Emergency Planning and Community Right-to-Know Act section 313 EPCRA/TRI training materials | 1 |
| EP 5.8:H 22/V.1-3 | OPPTS harmonized test guidelines. Series 870. Health effects | 1 |
| EP 5.8:H 33 |
Hazard identification toxicology endpoint selection process : a guidance document Hazard identification : toxicology endpoint selection process : a guidance document |
2 |
| EP 5.8:H 34/3/ACUTE | Health effects test guidelines: OPPTS 870.1000 acute toxicity testing--background | 1 |
| EP 5.8:H 34/3/ACUTE-2/DRAFT | Health effects test guidelines: OPPTS 870.1100 acute oral toxicity | 1 |
| EP 5.8:H 34/3/ACUTE-3/DRAFT | Health effects test guidelines : OPPTS 870.1200 acute dermal toxicity | 1 |
| EP 5.8:H 34/3/ACUTE-4/DRAFT | Health effects test guidelines : OPPTS 870.1300 acute inhalation toxicity | 1 |
| EP 5.8:H 34/3/ACUTE-5/DRAFT | Health effects test guidelines : OPPTS 870.2400 acute eye irritation | 1 |
| EP 5.8:H 34/3/ACUTE-6/DRAFT | Health effects test guidelines : OPPTS 870.2500 acute dermal irritation | 1 |
| EP 5.8:H 34/3/COMBINED | Health effects test guidelines : OPPTS 870.8355 combined chronic toxicity/carcinogenicity testing of respirable fibrous particles | 1 |
| EP 5.8:H 34/3/DAY/DRAFT | Health effects test guidelines: OPPTS 870.3100 90-day oral toxicity | 1 |
| EP 5.8:H 34/3/DOSE | Health effects test guidelines : OPPTS 870.3050 repeated dose 28-day oral toxicity study in rodents | 1 |
| EP 5.8:H 34/3/INHALATION/DRAFT | Health effects test guidelines : OPPTS 870.3600 inhalation developmental toxicity study | 1 |
| EP 5.8:H 34/3/METABOLISM/DRAFT | Health effects test guidelines: OPPTS 870.7485 metabolism and pharmacokinetics | 1 |
| EP 5.8:H 34/3/PRELIMINARY/DRAFT | Health effects test guidelines: OPPTS 870.3500 preliminary developmental toxicity screen | 1 |
| EP 5.8:H 34/3/REPEATED/DRAFT | Health effects test guidelines: OPPTS 870.3200 repeated dose dermal toxicity--21/28 days | 1 |
| EP 5.8:H 34/3/SKIN/DRAFT | Health effects test guidelines : OPPTS 870.2600 skin sensitization | 1 |
| EP 5.8:H 34/3/SUBCHRONIC-2/DRAFT | Health effects test guidelines: OPPTS 870.3250 subchronic dermal toxicity--90 days | 1 |
| EP 5.8:H 34/3/SUBCHRONIC-3/DRAFT | Health effects test guidelines: OPPTS 870.3465 subchronic inhalation toxicity | 1 |